Dianne E. van der Wal: Advancing Platelet Research at ISTH 2026 in Paris
Dianne E. van der Wal, Honorary Lecturer at the University of Sydney, Researcher at the ANZAC Research Institute, and Editor at Platelets journal, shared Platelets Journal’s post on LinkedIn:
“Share your exciting platelet research with us now.
Quoting Platelets Journal’s post:
“Still buzzing from the International Society on Thrombosis and Haemostasis (ISTH) Congress 2026 in Paris!
Meet some of the faces behind the Platelets team; many of whom you’ll no doubt have seen as chairs, speakers and poster presenters, from all corners of the world.
It was an absolute pleasure to meet so many of our authors and readers face to face. A slightly belated, but very heartfelt, thank you to everyone who made this conference extra special.
From left to right: Jianlin Qiao (Principle Editor), Craig Jenne (Principle Editor), Marie Lordkipanidze (Systematic Reviews Editor), Emma Josefsson (Principle Editor), Samantha Montague (Principle Editor), Elizabeth Gardiner (Editor-in-Chief), David Stegner (Method Section Editor), William Parker (Editor-in-Chief), Matthew Harper (Review Editor), Neil Morgan (Principle Editor) and Dianne E. van der Wal Ph.D. (Principle Editor).”
Stay updated with Hemostasis Today.
-
Aug 29, 2026, 16:44Nipocalimab for Warm Autoimmune Hemolytic Anemia: What the FDA Approval Means
-
Aug 29, 2026, 16:17The Future of Bleeding Disorder Research is Getting Bigger – Global Hemophilia Report
-
Aug 29, 2026, 16:03Marco De Giovanni: The Platelet – Serotonin Link Behind Severe COVID-19
-
Aug 29, 2026, 16:01FDA Approves Imaavy for wAIHA – Thalassaemia International Federation
-
Aug 29, 2026, 15:55Cory Dugan: Iron Deficiency and Anemia Across the Female Life
-
Aug 29, 2026, 15:53Melina Rodriguez: FDA Approves Imaavy as First Treatment for Warm AIHA
-
Aug 29, 2026, 15:50Karen T․: Seeking a Patient Liaison to Support the Bleeding Disorders Community
-
Aug 29, 2026, 15:49Ujjawal Agarwal: Alkem’s Fight Against Anemia in Rural Bihar
-
Aug 29, 2026, 15:44Christopher Cannon: Anticoagulation Shows Benefits Even in Low Risk Atrial Fibrillation Patients